Search

Your search keyword '"Cheng, Matthew P."' showing total 595 results

Search Constraints

Start Over You searched for: Author "Cheng, Matthew P." Remove constraint Author: "Cheng, Matthew P." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
595 results on '"Cheng, Matthew P."'

Search Results

1. Enhanced Superconducting Qubit Performance Through Ammonium Fluoride Etch

2. Formation and Microwave Losses of Hydrides in Superconducting Niobium Thin Films Resulting from Fluoride Chemical Processing

3. The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe.

4. Suppressed phase segregation for triple-junction perovskite solar cells

9. Memory Mates: An Evaluation of a Classroom-Based, Student-Focused Working Memory Intervention

10. Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities

12. A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19

13. Next-generation rapid phenotypic antimicrobial susceptibility testing.

14. Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.

18. Seroprevalence du SRAS-CoV-2 chez les travailleurs de la sante de 10 hopitaux du Quebec, au Canada : etude transversale

21. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

24. SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study

26. BK virus–specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation

27. Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literature

29. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial

30. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial

32. Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept

34. Reply to Dobler

37. qSOFA does not predict bacteremia in patients with severe manifestations of sepsis

38. Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia.

40. Proteomic Evolution from Acute to Post-COVID-19 Conditions.

43. Generer des donnees d'essais randomises pour optimiser le traitement a l'ere de la pandemie de COVID-19

44. A three-dimensional quantum dot network stabilizes perovskite solids via hydrostatic strain

45. Outcomes and characteristics of patients hospitalized for COVID-19 in British Columbia, Ontario and Quebec during the Omicron wave.

47. sj-docx-1-obm-10.1177_1753495X231163351 - Supplemental material for Walking the walk to include pregnant participants in non-obstetric clinical trials: Insights from the SNAP Trial

48. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

49. Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

50. Epidemiology and Disease Burden of Mucormycosis in Canada: Canmus Registry

Catalog

Books, media, physical & digital resources